Machine learning–based prediction of outcomes of the endoscopic endonasal approach in Cushing disease: is the future coming?

Author:

Zoli Matteo12,Staartjes Victor E.34,Guaraldi Federica12,Friso Filippo1,Rustici Arianna56,Asioli Sofia127,Sollini Giacomo18,Pasquini Ernesto18,Regli Luca3,Serra Carlo3,Mazzatenta Diego12

Affiliation:

1. Pituitary Unit, Center for the Diagnosis and Treatment of Hypothalamic-Pituitary Diseases, IRCCS Institute of Neurological Sciences of Bologna;

2. Department of Biomedical and Motor Sciences (DIBINEM), University of Bologna, Italy;

3. Department of Neurosurgery, Clinical Neuroscience Center, University Hospital of Zurich, University of Zurich, Switzerland;

4. Neurosurgery, Amsterdam Movement Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands;

5. Department of Neuroradiology, IRCCS Istitute of Neurological Sciences of Bologna;

6. Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna;

7. Section of Anatomic Pathology ‘M. Malpighi’ at Bellaria Hospital, Bologna; and

8. ENT Department, Bellaria Hospital, Bologna, Italy

Abstract

OBJECTIVEMachine learning (ML) is an innovative method to analyze large and complex data sets. The aim of this study was to evaluate the use of ML to identify predictors of early postsurgical and long-term outcomes in patients treated for Cushing disease (CD).METHODSAll consecutive patients in our center who underwent surgery for CD through the endoscopic endonasal approach were retrospectively reviewed. Study endpoints were gross-tumor removal (GTR), postsurgical remission, and long-term control of disease. Several demographic, radiological, and histological factors were assessed as potential predictors. For ML-based modeling, data were randomly divided into 2 sets with an 80% to 20% ratio for bootstrapped training and testing, respectively. Several algorithms were tested and tuned for the area under the curve (AUC).RESULTSThe study included 151 patients. GTR was achieved in 137 patients (91%), and postsurgical hypersecretion remission was achieved in 133 patients (88%). At last follow-up, 116 patients (77%) were still in remission after surgery and in 21 patients (14%), CD was controlled with complementary treatment (overall, of 131 cases, 87% were under control at follow-up). At internal validation, the endpoints were predicted with AUCs of 0.81–1.00, accuracy of 81%–100%, and Brier scores of 0.035–0.151. Tumor size and invasiveness and histological confirmation of adrenocorticotropic hormone (ACTH)–secreting cells were the main predictors for the 3 endpoints of interest.CONCLUSIONSML algorithms were used to train and internally validate robust models for all the endpoints, giving accurate outcome predictions in CD cases. This analytical method seems promising for potentially improving future patient care and counseling; however, careful clinical interpretation of the results remains necessary before any clinical adoption of ML. Moreover, further studies and increased sample sizes are definitely required before the widespread adoption of ML to the study of CD.

Publisher

Journal of Neurosurgery Publishing Group (JNSPG)

Subject

Neurology (clinical),General Medicine,Surgery

Reference134 articles.

1. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings;Knosp;Neurosurgery,1993

2. A generic support vector machine model for preoperative glioma survival associations;Emblem;Radiology,2015

3. The endoscopic versus the traditional approach in pituitary surgery;Frank;Neuroendocrinology,2006

4. Cushing’s disease: pathobiology, diagnosis, and management;Lonser;J Neurosurg,2017

5. Treatment of Cushing’s syndrome: an endocrine society clinical practice guideline;Nieman;J Clin Endocrinol Metab,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3